EXHIBIT 10.4 MANAGEMENT AGREEMENT THIS AGREEMENT made effective November 1, 2000 BETWEEN: Phage Therapeutics International Inc., a body corporate, duly incorporated under the Laws of the state of Florida, United States of America, having its head...Management Agreement • June 6th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
LEASELease • February 8th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EXHIBIT 10.2 MANAGEMENT AGREEMENT THIS AGREEMENT made effective September 1, 1998. BETWEEN: Phage Therapeutics International Inc., a body corporate, duly incorporated under the Laws of the state of Florida, United States of America, having its head...Management Agreement • February 8th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EXHIBIT 10.8 SECURITIES PURCHASE AGREEMENT DATED AS OF OCTOBER 23, 2000 BY AND BETWEEN PHAGE THERAPEUTICS INTERNATIONAL INC. AS THE ISSUER,Securities Purchase Agreement • June 6th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Florida
EXHIBIT 10.6 CONSULTING AGREEMENT Consulting Agreement THIS CONSULTING AGREEMENT, having an effective date of October 9, 2000 is made between Deirdre (Dee) E. Sweeney, doing business as Sweeney Regulatory Consulting (herein referred to as...Consulting Agreement • June 6th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
EXHIBIT 10.3 EMPLOYMENT AGREEMENTS Attached are the employee agreements for the following persons: Richard Herman Richard Honour Tracy Honour Doug Lee Kenneth Lehman (2 agreements) Larry Stylebo Lisa Goodrich EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT...Employment Agreement • June 6th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EXHIBIT 10.3 ------------ EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, effectively dated as of January 1, 2001, is made by and between Phage Therapeutics, Inc ("Company") and Richard C. Honour ("Employee"). W I T N E S E T H: ------------------...Employment Agreement • February 8th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
Exhibit 10.2 CONFIDENTIAL DISCLOSURE AGREEMENT --------------------------------- This agreement (the "Agreement") is made effective on this date, ____________, by and between Phage Therapeutics, Inc., 19017 - 120th Avenue NE, Suite 102, Bothel, WA...Confidential Disclosure Agreement • June 6th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
WARRANT AGREEMENT between PHAGE THERAPEUTICS INTERNATIONAL INC. and INTERWEST TRANSFER COMPANY, INC. Dated as of February 25, 2000Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Florida
THIS AGREEMENT, dated as of February 25, 2000, is between Phage Therapeutics International Inc., a Florida corporation, having a principal place of business located at 22116 - 23rd Drive SE, Bothell, Washington 98021 ("Phage" or the "Company"), and Inter-west Transfer Agency, Inc., a transfer company registered by the Securities and Exchange Commission having a principal place of business located at 1981 East Murray Holladay Road, Suite 100, Salt Lake City, Utah 84117 (the "Warrant Agent", and collectively with Phage referred to as the "Parties").
EXHIBIT 10.1 ------------ Advisory Agreements for John J. Majnarich and Michael C. Maloney ADVISORY AGREEMENT Phage Therapeutics, Inc. ("PhageTx" or the "Company") desires to engage the advisory services ("Services") of John J. Majnarich, PhD, as an...Advisory Agreement • April 9th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
EXHIBIT 10.1 ------------ Advisory Agreements for John J. Majnarich and Michael C. Maloney, Seymour Froman, Luiz Bermudez, and Tyler Kokjohn. ADVISORY AGREEMENT Phage Therapeutics, Inc. ("PhageTx" or the "Company") desires to engage the advisory...Advisory Agreement • June 6th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
QuickLinks -- Click here to rapidly navigate through this documentPhage Therapeutics International Inc • December 5th, 2001 • Services-commercial physical & biological research • Florida
THIS COMMON STOCK PURCHASE WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THE HOLDER HEREOF, BY PURCHASING THIS COMMON STOCK PURCHASE WARRANT, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT, OR (C) IF REGISTERED UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
WARRANT AMENDING AGREEMENTWarrant Amending Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
PHAGE THERAPEUTICS INTERNATIONAL, INC., a Florida corporation, having a principal place of business located at 19017 120th Avenue NE, Suite 102, Bothell, Washington 98011
EMPLOYMENT AGREEMENTEmployment Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EMPLOYMENT AGREEMENT dated April 1, 2001 ("Agreement") between Phage Therapeutics, Inc., a Washington corporation ("PhageTx"), and John S. Sundsmo, PhD, a resident of Vista, CA ("Employee"), each a "Party' and collectively the "Parties."
EMPLOYMENT AGREEMENTEmployment Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EMPLOYMENT AGREEMENT dated May 15, 2001 ("Agreement") between Phage Therapeutics, Inc., a Washington corporation ("Company"), and Somsak Vinitnantharat, PhD, a resident of Bothell, WA ("Employee"), (each a "Party" and collectively the "Parties").
SECOND AMENDMENT TO LEASE DATED JULY 1, 2001 TO LEASE DATED NOVEMBER 1, 2000 BETWEEN RAZORE LAND COMPANY ("LANDLORD") AND PHAGE THERAPEUTICS INTERNATIONAL ("TENANT")Phage Therapeutics International Inc • December 5th, 2001 • Services-commercial physical & biological research
WHEREAS, Landlord and Tenant have heretofore entered into that certain Lease dated November 1, 2000 (hereinafter referred to as the "Lease") under the terms of which Landlord leased to Tenant approximately 5,148 rentable square feet of space (hereinafter referred to as the "Premises") located at 19017 120th Avenue NE, Suite 102, Bothell, Washington.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Florida
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of September , 2000, between Phage Therapeutics International Inc., a Florida corporation ("Phage"), and the persons and entities listed on the Schedule of Purchasers attached to this Agreement (the "Purchasers")
MASTER AGREEMENT RELATING TO: CONTRACT SERVICES FOR BACTERIOPHAGE PRODUCT BETWEEN Phage Therapeutics International Inc. 19211-64th Place NE Kenmore, WA 98028-3380 USA and INTELLIgene Expressions, Inc. Edmonton Research Park 1938 - 94 Street Edmonton,...Master Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
THIS MASTER AGREEMENT ("Agreement") is made effective as of Monday September 11, 2000 ("Effective Date") by and between INTELLIgene Expressions Inc. ("INTELLIgene"), a corporation incorporated under the laws of the province of Alberta, with principal offices at Edmonton Research Park, 1938 - 94 Street, Edmonton, Alberta, Canada T6N 1 J3 and Phage Therapeutics International Inc. ("PTXX"), a corporation incorporated under the laws of the State of Florida, USA with offices at 19211-64th Place NE, Kenmore, WA 98028-3380 USA.
PHAGE THERAPEUTICS INTERNATIONAL INC. 601 Brickell Key Blvd, Suite 802 Miami, FL 33131 SUBSCRIPTION AGREEMENTSubscription Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
The undersigned hereby tenders this Subscription Agreement to you and applies for the purchase of shares for US$ each for an aggregate purchase price of US$ . Each Share consists of one common share with a par value of $0.001 per share (the "Shares").
EMPLOYMENT AGREEMENTEmployment Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EMPLOYMENT AGREEMENT dated May 1, 2001 ("Agreement") between Phage Therapeutics, Inc., a Washington corporation ("Company"), and Lisa M. Goodrich, BS, a resident of Bothell, WA ("Employee").
SECURITIES PURCHASE AMENDING AGREEMENTSecurities Purchase Amending Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
PHAGE THERAPEUTICS INTERNATIONAL, INC., a company incorporated under the laws of Florida, having an office and address at 19017 120th Avenue NE, Suite 102, Bothel, Washington 98011.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
This Stock Purchase Agreement ("Agreement") is dated as of May 1, 2001 between Phage Therapeutics International, Inc., a Florida corporation ("Phage International"); ("Vendor"); and ("Purchaser").
SUBSCRIPTION AGREEMENT PHAGE THERAPEUTICS INTERNATIONAL INC. REGULATION D - RULE 506 - OFFERINGPhage Therapeutics International Inc • December 5th, 2001 • Services-commercial physical & biological research
The undersigned (the "Purchaser") hereby tenders this Subscription Agreement to you and applies for the purchase of units for $0.70 each for an aggregate purchase price of $ . Each "Unit" consisting of one common share in the capital of the Company (a "Share") and one common share purchase warrant of the Company ("Warrant") at a price of $0.70 per Unit. Each whole Warrant entitles the holder to purchase one additional common share in the Company for $1.25 per share at any time on or before the end of one year from the date of acquisition of the Units and and thereafter for US$2.00 at any time on or before the end of two years from the date of acquisition. All sums are in US currency. THESE SECURITIES ARE CONSIDERED RESTRICTED SECURITIES IN UNITED STATES.
MANAGEMENT AGREEMENTManagement Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
Phage Therapeutics International Inc., a body corporate, duly incorporated under the Laws of the state of Florida, United States of America, having its head office situated at 22116 - 23rd Drive SE, Bothell, WA 98021
WARRANT AGREEMENT between PHAGE THERAPEUTICS INTERNATIONAL INC. and INTERWEST TRANSFER COMPANY, INC. Dated as of August , 2001Warrant Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Florida
THIS AGREEMENT, dated as of August , 2001, is between Phage Therapeutics International Inc., a Florida corporation, having a principal place of business located at 22116 - 23rd Drive SE, Bothell, Washington 98021 ("Phage" or the "Company"), and Interwest Transfer Agency, Inc., a transfer company registered by the Securities and Exchange Commission having a principal place of business located at 1981 East Murray Holladay Road, Suite 100, Salt Lake City, Utah 84117 (the "Warrant Agent", and collectively with Phage referred to as the "Parties").
PURCHASE AGREEMENTPurchase Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • British Columbia
Phage Therapeutics, Inc. ("Phage") is a company with business offices located in the State of Washington with a business in the research, development and marketing of bacteriophages.
FIRST AMENDMENT TO LEASE DATED MAY 1, 2001 TO LEASE DATED NOVEMBER 1, 2000 BETWEEN RAZORE LAND COMPANY ("LANDLORD") AND PHAGE THERAPEUTICS INTERNATIONAL ("TENANT")Phage Therapeutics International Inc • December 5th, 2001 • Services-commercial physical & biological research
WHEREAS, Landlord and Tenant have heretofore entered into that certain Lease dated November 1, 2000 (hereinafter referred to as the "Lease") under the terms of which Landlord leased to Tenant approximately 5,148 rentable square feet of space (hereinafter referred to as the "Premises") located at 19017 120th Avenue NE, Suite 102, Bothell, Washington.
STOCK PURCHASE AMENDING AGREEMENTPurchase Amending Agreement • December 5th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
PHAGE THERAPEUTICS INTERNATIONAL, INC., a company incorporated under the laws of Florida, having an office and address at 19017 120th Avenue NE, Suite 102, Bothel, Washington 98011.
